Press release
Exploring the Dynamic Growth of Pharmacogenomics: Predicting a $10,265.5 Million Market by 2025
Pharmacogenomics Market
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐: https://www.alliedmarketresearch.com/request-sample/5220
๐๐ก๐ ๐ฉ๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ก๐๐ซ๐๐๐ญ๐๐ซ๐ข๐ณ๐๐ ๐๐ฒ ๐ ๐ซ๐๐ง๐ ๐ ๐จ๐ ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ, ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ง๐ ๐๐ง๐ ๐ฎ๐ฌ๐๐ซ๐ฌ. ๐๐๐ซ๐ ๐๐ซ๐ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ก๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง ๐๐๐ญ๐๐ข๐ฅ:
1. Technology: a. Next Generation Sequencing: Next-generation sequencing (NGS) plays a crucial role in pharmacogenomics by enabling the rapid and cost-effective analysis of an individual's genetic makeup. NGS technology offers high-throughput sequencing capabilities, allowing for the identification of genetic variations associated with drug response. b. Polymerase Chain Reaction (PCR): PCR is a widely used technique in pharmacogenomics that amplifies specific DNA segments for analysis. It is employed to detect genetic variants and polymorphisms relevant to drug metabolism and treatment response. c. Gel Electrophoresis: Gel electrophoresis is a traditional method used to separate and analyze DNA fragments based on their size. It has been employed in pharmacogenomics research for DNA profiling and genotyping. d. Mass Spectrometry: Mass spectrometry is a powerful analytical technique used to measure the molecular weight and chemical composition of compounds. It has applications in pharmacogenomics for the analysis of drug metabolites and biomarkers. e. Microarray: Microarray technology allows for the simultaneous analysis of thousands of genetic markers. It has been extensively used in pharmacogenomics to study gene expression profiles and identify biomarkers associated with drug response. f. Others: The pharmacogenomics market also includes other emerging technologies, such as CRISPR-Cas9 gene editing, digital PCR, and single-cell sequencing, which are advancing the understanding of genetic variations and their impact on drug response.
2. Application: a. Cardiovascular Disease: Pharmacogenomics has applications in the treatment and prevention of cardiovascular diseases by identifying genetic factors influencing drug response and tailoring therapies accordingly. b. Infectious Diseases: Understanding genetic variations related to infectious diseases can help optimize drug selection and dosage for improved patient outcomes. c. Oncology: Pharmacogenomics plays a vital role in oncology by identifying genetic markers that can predict response to cancer therapies, enabling personalized treatment approaches. d. Neurological Diseases: Genetic factors can significantly influence the efficacy and safety of drugs used in the treatment of neurological conditions, making pharmacogenomics valuable in this field. e. Psychiatry: Pharmacogenomics can assist in psychiatric treatment by identifying genetic markers associated with drug response and potential adverse reactions. f. Others: Pharmacogenomics is also applicable to various other therapeutic areas, such as autoimmune diseases, respiratory disorders, and gastrointestinal conditions, among others.
3. End User: a. Hospitals and Clinics: Hospitals and clinics are the primary end users of pharmacogenomic testing. Integration of pharmacogenomic data into clinical practice enables healthcare providers to make informed treatment decisions and enhance patient outcomes. b. Research Institutions: Research institutions, including pharmaceutical companies and biotechnology firms, drive innovation in pharmacogenomics. They conduct studies to elucidate the genetic basis of drug response and develop novel therapeutic approaches. c. Academic Institutes: Academic institutes contribute to pharmacogenomics research through collaborative studies, training programs, and academic publications. They play a crucial role in advancing knowledge and educating future professionals in the field.
Key Market Players
๐๐ง๐๐๐ฆ๐, ๐๐๐, ๐๐๐ฆ๐๐ซ๐ ๐๐๐๐ฅ๐ญ๐ก, ๐๐๐๐ ๐๐๐๐ฅ๐ญ๐ก, ๐๐ง๐. (๐๐๐ง๐๐๐ฑ.), ๐๐ฅ๐ฅ๐ฎ๐ฆ๐ข๐ง๐, ๐๐ง๐., ๐๐๐๐จ๐ญ๐ญ ๐๐๐๐จ๐ซ๐๐ญ๐จ๐ซ๐ข๐๐ฌ, ๐๐ก๐๐ซ๐ฆ๐จ ๐ ๐ข๐ฌ๐ก๐๐ซ ๐๐๐ข๐๐ง๐ญ๐ข๐๐ข๐, ๐๐ง๐., ๐ . ๐๐จ๐๐๐ฆ๐๐ง๐ง-๐๐ ๐๐จ๐๐ก๐ ๐๐ญ๐., ๐๐ฒ๐ซ๐ข๐๐ ๐๐๐ง๐๐ญ๐ข๐๐ฌ ๐๐ง๐., ๐๐ฒ๐ง๐๐ฆ๐ข๐ ๐๐๐ ๐๐๐๐จ๐ซ๐๐ญ๐จ๐ซ๐ข๐๐ฌ, ๐๐ฆ๐ฉ๐ข๐ซ๐ ๐๐๐ง๐จ๐ฆ๐ข๐๐ฌ, ๐๐๐.
๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐-
DNA Diagnostics Market - https://www.alliedmarketresearch.com/dna-diagnostics-market
Biomaterials Market - https://www.alliedmarketresearch.com/biomaterials-market
Asthma and COPD Drugs Market - https://www.alliedmarketresearch.com/asthma-COPD-drug-market
Atrial Fibrillation Market - https://www.alliedmarketresearch.com/atrial-fibrillation-market
Remote Patient Monitoring Market -
https://www.alliedmarketresearch.com/remote-patient-monitoring-market
Vaccines Market - https://www.alliedmarketresearch.com/vaccines-market
Dental Consumables Market - https://www.alliedmarketresearch.com/dental-consumables-market
Sports Medicine Market - https://www.alliedmarketresearch.com/Sports-Medicine-market
Breast Biopsy Market - https://www.alliedmarketresearch.com/Breast-Biopsy-market
External Defibrillators Market - https://www.alliedmarketresearch.com/external-defibrillators-market
Blood Market - https://www.alliedmarketresearch.com/blood-market
Insomnia Market - https://www.alliedmarketresearch.com/insomnia-market
Indian Dental Consumables Market -
https://www.alliedmarketresearch.com/indian-dental-consumables-market
Intraoral Scanners Market - https://www.alliedmarketresearch.com/intraoral-scanners-market
UK IVD Market - https://www.alliedmarketresearch.com/uk-ivd-market
Ulcerative Colitis Market- https://www.alliedmarketresearch.com/ulcerative-colitis-market
Lateral Flow Assays Market https://www.alliedmarketresearch.com/lateral-flow-assay-market
Safety Needles Market https://www.alliedmarketresearch.com/safety-needles-market
Enteral Nutrition Market https://www.alliedmarketresearch.com/enteral-nutrition-market
pharmacogenomics market https://www.alliedmarketresearch.com/pharmacogenomics-market
Laboratory Equipment and Disposables Market https://www.alliedmarketresearch.com/laboratory-equipment-and-disposables-market
Cell Therapy Market
https://www.alliedmarketresearch.com/cell-therapy-market
Irritable Bowel Syndrome Treatment Market https://www.alliedmarketresearch.com/irritable-bowel-syndrome-treatment-market-A05948
Disposable Syringes Market https://www.alliedmarketresearch.com/disposable-syringes-market-A06120
Pharmaceutical Drug Delivery Market https://www.alliedmarketresearch.com/pharmaceutical-drug-delivery-market-A06102
VR In Healthcare Market https://www.alliedmarketresearch.com/vr-in-healthcare-market-A06193
Inhaled Nitric Oxide Market https://www.alliedmarketresearch.com/inhaled-nitric-oxide-market
Oral Antibiotics Market https://www.alliedmarketresearch.com/oral-antibiotics-market-A06540
Surrogacy Market https://www.alliedmarketresearch.com/surrogacy-market-A06580
Neurorehabilitation Market https://www.alliedmarketresearch.com/neurorehabilitation-market-A10461
European Antibiotics Market https://www.alliedmarketresearch.com/european-antibiotics-market-A10311
Cardiac Mapping Market https://www.alliedmarketresearch.com/cardiac-mapping-market-A10920
Cellulite Treatment Market https://www.alliedmarketresearch.com/cellulite-treatment-market-A10923
Blepharoplasty Market https://www.alliedmarketresearch.com/blepharoplasty-market-A10890
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exploring the Dynamic Growth of Pharmacogenomics: Predicting a $10,265.5 Million Market by 2025 here
News-ID: 3087077 • Views: โฆ
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collectโฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโฆ
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
โข F. Hoffmann-la Roche Ltd
โข Abbott
โข Oxford Nanopore Technologies
โข Thermo Fisher Scientific Inc.
โข Illumina, Inc.
โข QIAGEN
โข Agilent Technologies, Inc.
โข Myriad Genetics, Inc.
โข Admera Health
Contact Us:
If you have any queries aboutโฆ
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 toโฆ
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis ofโฆ
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with theirโฆ
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complexโฆ
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certainโฆ
